blade grass mower miss cardin
view cardin report strong result pharma
segment outperform expect addit benefit tax
lower deal expens view result posit despit difficult
solid result report ep exclud benefit
tax includ compar street medic
segment essenti in-lin consensu adjust lower
oper incom vs street
forecast pharma beat combin revenu
strength y/i oper margin ahead
street ahead forecast cardin rais guidanc
 reflect benefit lower tax rate
assumpt chang net
tax rate confus cardin guid tax rate caus confus
among investor manag expect full year effect tax rate
provid benefit rel prior
guidanc benefit occur
compani appli effect tax rate across whole year
benefit quarter recogn benefit
quarter tax rate expect come slightli
provid modest benefit year
rais estim mostli tax adjust estim
reflect slightli stronger forecast pharma segment impact
sale china busi lower expect perform
medic relat cordi exam glove tax rate chang
revis ep estim ep estim increas
larg benefit tax rate assumpt well
modest increas pharma segment oper profit forecast
maintain sector perform maintain sector perform rate
share increas price target reflect
rais ep estim multipl increas half turn
reflect strength pharma segment despit gener drug price
valu usd unless otherwis note
price prior trade day market close estimate unless otherwis note
cardin health one three larg drug wholesal
unit state believ share like
multipl range-bound investor get visibl
gener drug price bottom oper
earn growth resum compani
pressur last month gener drug price
deflat increas wholesal competit higher-margin
independ custom slowdown brand drug price
increas weigh result expect
backdrop improv next twelv month end
believ investor expect estim
compani core drug distribut segment bottom
could continu disappoint
estim cardin gener
profit core us drug distribut busi sale
gener drug past two year cardin seen
price gener drug deflat high singl digit mid-teen
percentag rate profit dollar contribut fall
slightli lower rate cardin grow profit gener
drug need volum growth new introduct off-set
impact drug price deflat believ
possibl gener deflat continu high singl digit
pace higher thu current environ persist
upsid risk rate includ stabil drug
price environ could caus earn estim
stabil like drive multipl expans close
outperform expect drive posit earn
gener market potenti client loss
wholesal sell side price compress
larger pharmaci custom gpo
bloomberg capit market estim upside/downside/target
price target share equal prior
ep estim use multipl
reflect year averag forward trade multipl
upsid scenario share base
ep estim higher base case price-to-earnings
multipl appli ep upsid scenario
ep better ep growth could driven
success medic devic strategi increas volum across
brand gener drug de-lever balanc sheet
level gener price deflat forward
multipl repres high end normal trade
rang drug wholes space multipl
like get neg share
downsid scenario share base
ep estim base case price-to-earnings multipl
appli ep scenario downsid scenario
ep lower expect ep could
driven hiccup implement medic devic
strategi wors expect price environ lower
expect brand gener volum forward
multipl like get posit share
result varianc tabl act commentsrevenuepharmacet growth specialtymed profitpharmaceut oper oper adj better expect marginsmed adj benefit lower inventori adj costtot adj op incom expense- interest loss debt extinguishment- profit incom cont profit incom adjust tax benefit full year reduct adjust rateadj net ep dilut cont acq-rel discontinu op adjust ep dilut cont adjust ep exclud tax benefitweight average number share healthbp profitadj oper profit healthcar technolog distribut
price target share equal ep estim use
multipl reflect year averag forward trade multipl share
risk rate price target
forese upsid downsid risk sector perform rate share
upsid risk includ stabil drug price environ could caus earn
estim stabil like drive multipl expans close market multipl
cah medic surgic busi could also outperform expect drive posit
earn surpris downsid risk includ acceler drug price deterior
gener market potenti client loss wholesal sell side
price compress larger pharmaci custom gpo
healthcar servic product compani offer solut health
system pharmaci healthcar provid compani oper
medic segment busi distributor
brand gener drug specialti drug over-the-counter healthcar product
segment also provid specialti pharmaci servic china joint ventur
call red oak sourc sourc gener pharmaceut
medic busi distributor nation brand medic surgic
laboratori product healthcar provid patient home segment addit
provid profession servic healthcar provid
good sold
revenu
impair charg net
litig credit net
revenu
adj profit tax
profit tax
weight average number share
